RNF43 mutation as a predictor of immunotherapeutic efficacy in colorectal cancer

被引：0
|
作者：
Yu, Changjun [1 ]
Kang, Weibiao [1 ]
Yuan, Yu [1 ]
Zhang, Junling
Huang, Mengli [2 ]
Chen, Yanan [2 ]
Xia, Xihua [2 ]
Bai, Yuezong [2 ]
机构：
[1] First Affiliated Hosp Anhui Med Univ, Hefei, Peoples R China
[2] 3D Med Inc, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5089
引用
收藏
页数：2
相关论文
共 50 条
  • [1] RNF43 mutation as a predictor of immunotherapeutic efficacy in colorectal cancer
    Huang, Kaibin
    Ding, Shunkai
    Chen, Kai
    Guo, Chunhua
    Wu, Mingyi
    Zhang, Rui
    Wang, Luolin
    Fu, Yuxiang
    Xiao, Jinfeng
    Liu, Xianming
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (11): : 5549 - +
  • [2] RNF43 pathogenic Germline variant in a family with colorectal cancer
    Mikaeel, Reger R.
    Young, Joanne P.
    Li, Yun
    Poplawski, Nicola K.
    Smith, Eric
    Horsnell, Mehgan
    Uylaki, Wendy
    Tomita, Yoko
    Townsend, Amanda R.
    Feng, Jinghua
    Zibat, Arne
    Kaulfuss, Silke
    Mueller, Christian
    Yigit, Goekhan
    Wollnik, Bernd
    Scott, Hamish
    Rawlings, Lesley
    Henry, Denae
    Vakulin, Cassandra
    Dubowsky, Andrew
    Price, Timothy J.
    CLINICAL GENETICS, 2022, 101 (01) : 122 - 126
  • [3] Rnf43
    Serra, Stefano
    Chetty, Runjan
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (01) : 1 - 6
  • [4] A novel oncoprotein RNF43 functions in an autocrine manner in colorectal cancer
    Yagyu, R
    Furukawa, Y
    Lin, YM
    Shimokawa, T
    Yamamura, T
    Nakamura, Y
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (05) : 1343 - 1348
  • [5] RNF43 IN COLITIS ASSOCIATED CANCER
    Dietl, Alisa
    Ralser, Anna
    Dregelies, Theresa
    Sterlacci, William
    Vieth, Michael
    Li, Xue
    Stadler, Mara
    Alarcon, Roberto Olayo
    Taxauer, Karin
    Kazeroonian, Atefeh
    Janssen, Klaus Peter
    Rad, Roland
    Muller, Christian L.
    Gerhard, Markus
    Mejias-Luque, Raquel
    GASTROENTEROLOGY, 2022, 162 (07) : S129 - S129
  • [6] RNF43 is frequently mutated in colorectal and endometrial cancers
    Giannakis, Marios
    Hodis, Eran
    Mu, Xinmeng Jasmine
    Yamauchi, Mai
    Rosenbluh, Joseph
    Cibulskis, Kristian
    Saksena, Gordon
    Lawrence, Michael S.
    Qian, Zhi Rong
    Nishihara, Reiko
    Van Allen, Eliezer M.
    Hahn, William C.
    Gabriel, Stacey B.
    Lander, Eric S.
    Getz, Gad
    Ogino, Shuji
    Fuchs, Charles S.
    Garraway, Levi A.
    NATURE GENETICS, 2014, 46 (12) : 1264 - 1266
  • [7] KMT2C mutation as a predictor of immunotherapeutic efficacy in colorectal cancer
    Ni, Chunhua
    Wang, Xiaohong
    Liu, Shaoping
    Zhang, Junling
    Luo, Zhongguang
    Xu, Bei
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [8] RNF43 is frequently mutated in colorectal and endometrial cancers
    Marios Giannakis
    Eran Hodis
    Xinmeng Jasmine Mu
    Mai Yamauchi
    Joseph Rosenbluh
    Kristian Cibulskis
    Gordon Saksena
    Michael S Lawrence
    Zhi Rong Qian
    Reiko Nishihara
    Eliezer M Van Allen
    William C Hahn
    Stacey B Gabriel
    Eric S Lander
    Gad Getz
    Shuji Ogino
    Charles S Fuchs
    Levi A Garraway
    Nature Genetics, 2014, 46 : 1264 - 1266
  • [9] RNF43 is associated with genomic features and clinical outcome in BRAF mutant colorectal cancer
    Shang, Peipei
    Lu, Jiongjiong
    Song, Feihong
    Zhao, Yijun
    Hong, Weipeng
    He, Yuange
    Shen, Weidong
    Geng, Li
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [10] RNF43 is a frequent mutational target in serrated colorectal neoplasia
    Whitehall, Vicki L.
    Bond, Catherine
    McKeone, Diane
    Ellis, Jonathan
    Bettington, Mark
    Pearson, Sally
    Leggett, Barbara
    CANCER RESEARCH, 2015, 75
12345